€ 16.91
Key Takeaways
Risk factor
Weak & very vulnerable to price shocks
Profitability factor
Favourable analyst view
About
Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide. It operates in two segments, Medical and Isotope Products. The Medical segment offers small radioactive implants for the treatment of prostate cancer seeds; and eye application based on ruthenium-106 or iodine-125 for...
Company Valuation
From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA, o
Target Price
The average target price of EUZ.DE is 23 and suggests 36% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
